RecruitingNCT06913712

BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment

Evolution of Body Mass Index in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment. Retrospective and Prospective Study

Sponsor

University of Valencia

Enrollment

25 participants

Start Date

Jun 27, 2024

Study Type

OBSERVATIONAL

Conditions

Idiopathic Intracranial Hypertension (IIH)

Summary

1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3. To establish how much the BMI must be reduced to cure this disease. 4. To assess the evolution and response to treatments of sick people who DO NOT reduce or even continue to increase their BMI despite treatment with Acetazolamide or a possible CSF diversion

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Adults aged 18 years and older at the time of enrollment. There is no upper age limit to ensure inclusivity across age ranges.
A confirmed diagnosis of Idiopathic Intracranial Hypertension, established according to the Dandy criteria.
The diagnostic process must exclude other potential causes of increased intracranial pressure as detailed in the 'Diagnosis' section, ensuring an accurate identification of idiopathic cases.

Exclusion Criteria2

A diagnosis other than IIH, specifically: tension-type headache, Chiari I malformation, or any other headache disorder unrelated to IIH.
The presence of secondary causes of increased intracranial pressure (e.g., structural brain abnormalities, venous sinus thrombosis, or medication-induced factors).

Interventions

OTHERWeight loss without pharmacotherapy

The study will record the weight of the patients with Idiopathic Intracranial Hypertension every three months. It will correlate with the response to the different treatment modalities (weight loss with no other intervention, diuretic drugs (acetazolamide), lumboperitoneal shunt, or ventriculoperitoneal shunt). No medication will be provided to help lose weight.